research laboratories

Kenya will next year release two hybrid maize seeds that are resistant to Maize Lethal Necrosis (MLN) which has been ravaging the maize crop, a researcher said on Saturday.

James Karanja, maize breeder at Kenya Agricultural and Livestock Research Organization (KALRO) told journalists that already two varieties have been licensed to seed companies to reproduce for farmers.

“The varieties are already being produced by private seed companies and will be in the market by April 2020,” Karanja said.

He said that the seeds that have been developed through collaboration with the International Maize and Wheat Improvement Centre will save farmers from making losses associated with MLN disease.

Karanja said that so far only one variety DK 777 that has been commercialized by Monsanto is in the market.

MLN disease was discovered in Kenyan farms in 2011 and ended up causing devastation that led to farmers making huge losses.

The disease proved difficult to control forcing KALRO and global research organizations, private sector and seed companies to control the spread of the disease. Enditem

Disclaimer: News Ghana is not responsible for the reportage or opinions of contributors published on the website.

Send your news stories to [email protected] and via WhatsApp on +1-508-812-0505 

For Latest Updates Follow us on Google News
Previous article3 killed in central Nigeria boat mishap
Next articleAU lauds Ethiopian troops for opening main supply routes, clearing explosives
Xinhua News Agency, Xinhuanet is an important central news service-oriented website, an important information organ of the central government, and an important platform for building up China's online international communication capacity. Established on November 7, 1997, as an online news provider of the Xinhua News Agency, it was officially named Xinhuanet on March 10, 2000 and began around-the-clock news release with leading online public opinion at home and setting a good image of China abroad as its main task.


Please enter your comment!
Please enter your name here